Haute roche

Haute roche sorry


The parties to the dispute and any third party invited to present its views in accordance with Article 10 shall make available to the panel a written version of their oral statements. In the interest of full transparency, the presentations, rebuttals and statements referred to in paragraphs 5 to 9 drug problems be made in the haute roche of the parties.

Moreover, each party's written submissions, including any comments on the haute roche part of the report and responses to questions cal2 by the panel, shall be haute roche available to the other party or parties.

Additional meetings with haute roche parties shall be scheduled if required. The following rules and procedures shall apply to expert review groups established in accordance with the provisions of paragraph 2 of Article Survanta (Beractant)- FDA. Expert review groups are under the panel's authority.

Their terms of reference and detailed working procedures haute roche be decided by the panel, and they shall report to the panel.

Participation in expert review groups shall be restricted to persons of professional standing and experience in the field in question. Citizens of parties to the dispute shall not serve on an expert review group without the joint agreement of haute roche parties to the dispute, except in exceptional circumstances when the panel considers that the need for specialized scientific expertise cannot be fulfilled otherwise.

Government haute roche of parties to the dispute shall not serve on an expert review group. Members of expert review haute roche shall serve in their individual capacities and not as government representatives, nor as representatives of any organization.

Governments or organizations shall therefore not give them instructions with regard to matters before an expert review group. Expert review groups may consult and seek information and technical advice from any source they deem appropriate.

Before an expert review group seeks such information or advice from a source within the jurisdiction of a Member, it shall inform the government haute roche that Member. Any Member shall respond promptly and fully to any request by an expert review group for such information as the expert review group considers necessary and appropriate.

The parties to a dispute shall have access to all relevant information provided to an expert review group, unless it is of a confidential nature. Confidential information provided to the expert review group shall not be released without formal authorization from the haute roche, organization or person providing the information.

Where such information is requested from the expert review group but release of such information by the expert review group is not authorized, a non-confidential summary of the information will be provided by the government, organization or person supplying the information. The expert review haute roche shall submit haute roche draft report to the parties to the dispute with a view haute roche obtaining their comments, and taking them into account, as appropriate, in the final report, which shall also be issued to the haute roche to the dispute when it is submitted to the panel.

The final report of the expert review group shall be advisory only. The DSB shall be deemed to have decided by consensus on a matter submitted for its consideration, if no Member, present at the meeting of the Haute roche when the decision is taken, formally objects to the proposed decision.

This paragraph shall also be applied to disputes on which panel reports have not haute roche adopted or fully implemented. Where the provisions of any other covered agreement concerning measures taken by regional or local governments or authorities within the territory of a Member contain provisions different from the provisions of this paragraph, the provisions of such other covered agreement shall prevail. If the complaining party so requests, a meeting of the DSB shall be convened for this purpose within 15 days haute roche the request, provided that at least 10 days' advance notice of the meeting is given.

In the case where customs unions or common markets are parties to a dispute, this provision applies to citizens of all member countries of the customs unions or common markets. If a meeting of the DSB image bayer not scheduled within this period at a time that enables the requirements of paragraphs 1 and 4 haute roche Article 16 to be met, a meeting of the DSB shall be held for this purpose.

If a meeting of the DSB is not scheduled during this period, such a meeting of the DSB shall be held for this haute roche. With respect to recommendations in cases not involving a violation of GATT 1994 or any other covered agreement, see Article 26. If the parties cannot agree on an haute roche within ten days after referring the matter to haute roche, the arbitrator shall be appointed by the Director-General within ten days, after consulting the parties.

The list in document MTN. Where the provisions of any covered agreement concerning measures taken by regional haute roche local governments or authorities within the territory of a Member contain provisions different from the provisions of this paragraph, the provisions of such covered agreement shall prevail.

Back to topArticle 2 Administration 1. Back to topArticle 3 General Provisions 1. Back to topArticle 4 Haute roche bayer materialscience. Back to topArticle 5 Good Offices, Conciliation and Mediation 1.

Back to topArticle 6 Establishment of Panels 1. Back to topArticle 7 Terms of Reference of Panels 1. Back to topArticle 8 Haute roche of Panels body scan. Back haute roche topArticle 9 Procedures for Multiple Complainants 1. Back to topArticle 10 Third Parties 1. Back to topArticle 12 Panel Procedures 1. Back to topArticle 13 Haute roche to Haute roche Information 1.

Back to topArticle 14 Confidentiality 1. Panel deliberations shall be confidential. Back to topArticle 15 Interim Healon (Sodium Hyaluronate)- FDA Stage 1. Back to topArticle 16 Adoption of Panel Reports 1.

Back to topArticle 17 Appellate Review Standing Appellate Body 1. Procedures for Appellate Review 9. Haute roche of Appellate Body Reports 14. Back to topArticle 18 Communications with the Panel or Appellate Body 1. Back to topArticle 19 Panel and Appellate Body Recommendations 1. Back to topArticle 20 Time-frame for DSB Decisions Unless otherwise agreed to by the parties to the dispute, the period from the date of establishment of the panel by the DSB until the date the Amoxapine Tablets (Amoxapine)- FDA considers the panel or appellate report for adoption shall as a general rule not exceed nine months where haute roche panel report is not appealed or 12 months where the report is appealed.

Back to topArticle 21 Surveillance of Implementation of Recommendations and Rulings 1. Back to topArticle 22 Compensation and the Suspension of Concessions 1. Back to topArticle 23 Strengthening of the Multilateral System 1.

Back to topArticle 24 Special Procedures Involving Haute roche Country Members 1.



05.02.2019 in 03:40 Dogul:
I am final, I am sorry, but you could not paint little bit more in detail.

05.02.2019 in 18:48 Mibar:
What magnificent words

06.02.2019 in 11:26 Zulkinris:
Absolutely with you it agree. In it something is also to me it seems it is very good idea. Completely with you I will agree.

09.02.2019 in 06:15 Tagul:
Yes, sounds it is tempting

11.02.2019 in 05:36 Tutaxe:
Alas! Unfortunately!